Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03026790 · ClinicalTrials.gov registry record · Phase 2
Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 820
- Enrollment target
NCT03026790 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 820 participants.
The verdict
NCT03026790, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 820 participants
- Enrollment target
Study Summary
Background and significance: Treatment with opioid pain medications (like hydrocodone and morphine) is common for severe pain, but studies show these medications may not always help and can cause serious problems. High daily doses of opioids can be especially unsafe. To help patients with chronic pain have better quality of life and avoid medication toxicity, health care teams need to manage pain while helping patients reduce opioid medication doses to safer levels.
Interventions
- DRUG Buprenorphine-Naloxone
- OTHER Medication management
- OTHER Non-pharmacological pain management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 820 participants |
| Start Date | 2017-10-19 |
| Est. Completion | 2022-10-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03026790
The ClinicalTrials.gov registry entry for NCT03026790 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 820 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Buprenorphine-Naloxone is the first listed.
NCT03026790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03026790 about?
NCT03026790 is a clinical study titled "Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study". Background and significance: Treatment with opioid pain medications (like hydrocodone and morphine) is common for severe pain, but studies show these medications may not always help and can cause serious problems. High daily doses of opioids can be especially unsafe. To help patients with chronic pa...
What is the current status of trial NCT03026790?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 820 participants. The study started on 2017-10-19. Estimated completion is 2022-10-30.
What interventions are being tested in trial NCT03026790?
The interventions under investigation include: Buprenorphine-Naloxone (DRUG), Medication management (OTHER), Non-pharmacological pain management (OTHER).
Who is sponsoring clinical trial NCT03026790?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.